DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
COO logo

The Cooper Companies, Inc. Stock Price

NasdaqGS:COO Community·US$10.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 33 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

COO Share Price Performance

US$53.78
-13.45 (-20.00%)
​
US$67.43
Fair Value
US$53.78
-13.45 (-20.00%)
20.2% undervalued intrinsic discount
US$67.43
Fair Value
Price US$53.78
AnalystConsensusTarget US$67.43
AnalystLowTarget US$67.42
AnalystHighTarget US$84.69
Thu, 10 Sep 26
Fair ValueUS$67.43
Share Pricen/a

COO Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$67.43 20.2% undervalued intrinsic discount

COO: Share Buybacks And Merger Potential Will Drive Undervalued Stock Higher

0users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$67.42 20.2% undervalued intrinsic discount

Premium Contact Lenses And Fertility Services Will Support Stable But Uneven Future Performance

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$84.69 36.5% undervalued intrinsic discount

Premium Daily Contact Lenses And Fertility Services Will Shape A Stronger Long-Term Outlook

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
COO logo
Cooper Companies
20.2% undervalued intrinsic discount

COO: Share Buybacks And Merger Potential Will Drive Undervalued Stock Higher

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 10 Sep
Read Narrative
COO logo
Cooper Companies
36.5% undervalued intrinsic discount

Premium Daily Contact Lenses And Fertility Services Will Shape A Stronger Long-Term Outlook

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 10 Sep
Read Narrative
COO logo
Cooper Companies
20.2% undervalued intrinsic discount

Premium Contact Lenses And Fertility Services Will Support Stable But Uneven Future Performance

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 29 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
COO logo

COO: Future Upside Will Hinge On EPS Recovery And Expanded Buybacks

Fair Value: US$67.43 20.2% undervalued intrinsic discount
17 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
COO logo

Premium Daily Contact Lenses And Fertility Services Will Shape A Stronger Long-Term Outlook

Fair Value: US$84.69 36.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
COO logo

COO: Operational Restructuring And Buybacks Will Support A Balanced Outlook

Fair Value: US$67.42 20.2% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Very undervalued with proven track record.

0 Risks
5 Rewards
View Full Analysis

The Cooper Companies, Inc. Key Details

US$4.2b

Revenue

US$1.4b

Cost of Revenue

US$2.8b

Gross Profit

US$2.2b

Other Expenses

US$570.3m

Earnings

Last Reported Earnings
Jul 31, 2026
Next Reporting Earnings
n/a
3.00
65.93%
13.46%
30.5%
View Full Analysis

About COO

Founded
1958
Employees
15000
CEO
Albert White
WebsiteView website
www.coopercos.com

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Recent COO News & Updates

Seeking Alpha • Sep 15

Cooper Companies: A Little More Compelling At This Price

Summary Cooper Companies (COO) is re-rated from Sell to Hold after a 31% price decline, reflecting a more interesting risk/reward profile but ongoing growth concerns. COO's revenue growth remains weak, with core CooperVision revenues flat and management attributing this to distribution channel destocking, raising questions about underlying demand. Gross margin expansion to 67% is largely driven by inventory write-offs, making COO's margin improvement less robust than Alcon's operational gains. At a P/E of ~18 and P/FCF of 15, COO's valuation still appears rich given flatlining growth, especially compared to Alcon's stronger growth and margin trajectory. Read the full article on Seeking Alpha

Recent updates

No updates

The Cooper Companies, Inc. Competitors

CI logo

Cigna Group

Symbol: NYSE:CI
Market cap: US$74.1b
BSX logo

Boston Scientific

Symbol: NYSE:BSX
Market cap: US$63.6b
COR logo

Cencora

Symbol: NYSE:COR
Market cap: US$60.8b
CAH logo

Cardinal Health

Symbol: NYSE:CAH
Market cap: US$54.1b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide